Professor Wang Min, MD
Chief Medical Officer, SCVC Bali
Professor | Chief Physician | Senior Consultant Interventional Cardiologist
Director, Cardiology Ward, Wuhan Asia Heart Hospital | Master’s Graduate Supervisor
-
Profil
Professor Wang Min merupakan kardiolog intervensi senior dengan pengalaman luas dalam intervensi koroner, penanganan penyakit arteri koroner kompleks, serta penggunaan teknologi pencitraan dan evaluasi fisiologis kardiovaskular tingkat lanjut.
Sebagai Chief Medical Officer SCVC Bali, beliau membawa pengalaman lebih dari dua dekade dalam menangani prosedur intervensi koroner dengan volume tinggi, yang didukung oleh pengalaman akademik, klinis, dan kepemimpinan yang luas.
Professor Wang telah melakukan lebih dari 10.000 prosedur intervensi koroner, dengan volume tindakan sekitar 600 kasus per tahun. Bidang keahlian utama beliau mencakup penyakit arteri koroner kiri utama (left main coronary artery disease), lesi bifurkasi koroner, lesi koroner dengan kalsifikasi berat, chronic total occlusion (CTO), serta prosedur PCI kompleks dan berisiko tinggi.
Dalam praktik klinisnya, beliau menggunakan teknologi pencitraan koroner dan evaluasi fisiologis modern, termasuk IVUS, OCT, dan FFR, untuk mendukung penilaian anatomi dan fungsi pembuluh darah secara lebih presisi pada kasus penyakit koroner kompleks.
Di luar intervensi koroner, Professor Wang memiliki pengalaman klinis yang luas dalam menangani sindrom koroner akut, hipertensi, penyakit katup jantung, kardiomiopati, serta berbagai kondisi kardiovaskular kompleks dan kegawatdaruratan kardiovaskular.
Beliau juga aktif menerapkan berbagai strategi intervensi modern, termasuk intervensi CTO, rotational atherectomy untuk lesi dengan kalsifikasi kompleks, serta evaluasi koroner berbasis pemeriksaan fisiologis.
Professor Wang telah memegang berbagai posisi akademik dan profesional dalam komunitas kardiovaskular di Tiongkok, termasuk di Chinese Society of Cardiology serta berbagai organisasi kardiovaskular di tingkat provinsi dan kota. Aktivitas profesional beliau mencakup bidang penyakit jantung koroner, kesehatan kardiovaskular perempuan, hipertensi, pencegahan penyakit kardiovaskular, serta penyakit kardiovaskular terkait metabolik.
Beliau juga berperan sebagai mentor dalam National Cardiovascular Disease Interventional Diagnosis and Treatment Training Program di Tiongkok, berkontribusi dalam pendidikan dan pengembangan profesional para dokter kardiologi intervensi.
Profil Akademik & Penelitian
Kegiatan akademik Professor Wang mencakup berbagai bidang, termasuk intervensi koroner kompleks, fisiologi koroner, terapi antiplatelet, sindrom koroner akut, penyakit jantung struktural, serta teknologi pencitraan kardiovaskular tingkat lanjut.
Penelitian yang beliau publikasikan mencakup berbagai topik, antara lain:
- Prediksi Fractional Flow Reserve (FFR) berbasis angiografi
- PCI pada penyakit arteri koroner kiri utama yang tidak terlindungi (unprotected left main coronary artery disease)
- Respons terhadap terapi antiplatelet pada pasien acute coronary syndrome (ACS) dengan diabetes
- Intervensi dini pada NSTE-ACS berisiko tinggi
- Intervensi pada chronic total occlusion (CTO)
- Aritmia ventrikel terkait TAVR
- Terapi drug-coated balloon pada STEMI
- Evaluasi microvascular obstruction menggunakan cardiac magnetic resonance setelah primary PCI
Beliau juga aktif berpartisipasi dalam berbagai kegiatan akademik kardiovaskular tingkat nasional serta penyusunan konsensus ahli, termasuk inisiatif profesional yang berkaitan dengan penyakit kardiovaskular pada perempuan dan penatalaksanaan aritmia.
Pengalaman Internasional
Professor Wang pernah menjadi Visiting Scholar di Epworth Heart Centre, Australia, yang memperluas pengalaman klinis dan akademiknya dalam bidang kedokteran kardiovaskular dan kardiologi intervensi.
Kombinasi pengalaman prosedural dengan volume tinggi, keahlian dalam PCI kompleks, kontribusi akademik, serta pengalaman kepemimpinan klinis menjadi landasan peran beliau dalam memberikan layanan kardiovaskular di SCVC Bali.
Bidang Keahlian
Intervensi Koroner Kompleks
- Penyakit Arteri Koroner Kiri Utama (Left Main Coronary Artery Disease)
- Lesi Bifurkasi Koroner
- Chronic Total Occlusion (CTO)
- Lesi Koroner dengan Kalsifikasi Berat
- PCI Kompleks dan Berisiko Tinggi
- Sindrom Koroner Akut
Evaluasi Koroner Tingkat Lanjut
- Intravascular Ultrasound (IVUS)
- Optical Coherence Tomography (OCT)
- Fractional Flow Reserve (FFR)
- Evaluasi Fisiologi Koroner
- Pencitraan Koroner Tingkat Lanjut
Penanganan Kardiovaskular Komprehensif
- Penyakit Arteri Koroner
- Hipertensi
- Penyakit Katup Jantung
- Kardiomiopati
- Kondisi Kardiovaskular Akut dan Kritis
Jabatan Akademik & Profesional
- Chief Medical Officer, SCVC Bali
- Profesor dan Dokter Utama (Chief Physician)
- Direktur Ruang Rawat Inap Kardiologi, Wuhan Asia Heart Hospital
- Pembimbing Pascasarjana
- Mentor, National Cardiovascular Disease Interventional Diagnosis and Treatment Training Program – Coronary Intervention
- Anggota Komite, Chinese Society of Cardiology – Women’s Heart Health Group
- Anggota Komite, Chinese Society of Cardiology – Coronary Heart Disease & Atherosclerosis Group
- Anggota Komite, Chinese Research Hospitals Hypertension Professional Committee
- Anggota Komite, Hubei Cardiovascular Prevention Center Continuing Education Steering Committee
- Anggota Komite, Hubei Preventive Medicine Association Cardiovascular Prevention & Control Committee
- Anggota Komite Tetap, Wuhan Medical Association Cardiovascular Physicians Branch
- Ahli, Hubei Medical Malpractice Appraisal Committee
- Expert Reviewer, Wuhan Municipal Science and Technology Bureau
- Visiting Scholar, Epworth Heart Centre, Australia
Publikasi & Kontribusi Akademik Terpilih
Professor Wang Min telah berkontribusi dalam berbagai publikasi ilmiah dan konsensus ahli di bidang kardiologi, antara lain mengenai aritmia pada perempuan, hipertensi pada perempuan, penyakit jantung koroner pada perempuan, intervensi koroner kompleks, terapi antiplatelet, sindrom koroner akut, CTO, FFR, TAVR, dan intervensi koroner primer.
Beliau juga terlibat sebagai Expert Contributor dan anggota kelompok ahli dalam sejumlah konsensus nasional, termasuk konsensus mengenai penatalaksanaan hipertensi pada perempuan serta diagnosis dan tata laksana penyakit jantung koroner pada perempuan di Tiongkok.
Daftar publikasi mencakup karya ilmiah yang diterbitkan di berbagai jurnal kedokteran dan kardiologi, dengan topik penelitian yang meliputi penyakit arteri koroner kompleks, intervensi koroner, fisiologi koroner, terapi antiplatelet, sindrom koroner akut, serta teknologi pencitraan dan terapi kardiovaskular tingkat lanjut.
-
Overview
Professor Wang Min is a senior interventional cardiologist with extensive expertise in coronary intervention, complex coronary artery disease, and advanced cardiovascular imaging and physiology. As Chief Medical Officer of SCVC Bali, she brings more than two decades of high-volume interventional experience together with extensive academic, clinical, and leadership experience.
Professor Wang has performed more than 10,000 coronary interventions, with an annual procedural volume of approximately 600 cases. Her particular areas of expertise include left main coronary artery disease, coronary bifurcation lesions, heavily calcified lesions, chronic total occlusions (CTO), and other high-risk and complex PCI procedures.
Her practice incorporates contemporary coronary imaging and physiological assessment, including IVUS, OCT, and FFR, supporting precise anatomical and functional evaluation in complex coronary disease.
Beyond coronary intervention, Professor Wang has extensive clinical experience in acute coronary syndromes, hypertension, valvular heart disease, cardiomyopathy, and complex cardiovascular and critical-care conditions. She is actively involved in contemporary interventional strategies, including CTO intervention, rotational atherectomy for complex calcified lesions, and physiology-guided coronary assessment.
Professor Wang has held numerous academic and professional appointments within the Chinese cardiovascular community, including roles with the Chinese Society of Cardiology and cardiovascular organizations at the provincial and municipal levels. Her professional activities have encompassed coronary heart disease, women’s cardiovascular health, hypertension, cardiovascular prevention, and metabolic cardiovascular disease.
She also serves as a mentor within China’s National Cardiovascular Disease Interventional Diagnosis and Treatment Training Program, contributing to the education and professional development of interventional cardiologists.
Academic & Research Profile
Professor Wang’s academic work spans complex coronary intervention, coronary physiology, antiplatelet therapy, acute coronary syndromes, structural heart disease, and advanced cardiovascular imaging.
Her published research includes investigations into angiography-based prediction of FFR, PCI for unprotected left main coronary artery disease, antiplatelet response in ACS patients with diabetes, early intervention in high-risk NSTE-ACS, CTO intervention, TAVR-related ventricular arrhythmia, drug-coated balloon therapy in STEMI, and cardiac magnetic resonance assessment of microvascular obstruction following primary PCI.
She has also participated in national cardiovascular academic activities and expert consensus work, including professional initiatives addressing women’s cardiovascular disease and arrhythmia management.
International Experience
Professor Wang was a Visiting Scholar at Epworth Heart Centre, Australia, gaining further international clinical and academic exposure in cardiovascular medicine and interventional cardiology.
Her combination of high-volume procedural experience, complex PCI expertise, academic contribution, and clinical leadership forms the foundation of her role at SCVC Bali.
Areas of Expertise
Complex Coronary Intervention
- Left Main Coronary Artery Disease
- Coronary Bifurcation Lesions
- Chronic Total Occlusion (CTO)
- Heavily Calcified Coronary Lesions
- High-Risk and Complex PCI
- Acute Coronary Syndromes
Advanced Coronary Assessment
- Intravascular Ultrasound (IVUS)
- Optical Coherence Tomography (OCT)
- Fractional Flow Reserve (FFR)
- Coronary Physiological Assessment
- Advanced Coronary Imaging
Comprehensive Cardiovascular Care
- Coronary Artery Disease
- Hypertension
- Valvular Heart Disease
- Cardiomyopathy
- Acute and Critical Cardiovascular Conditions
Academic & Professional Appointments
- Chief Medical Officer, SCVC Bali
- Professor and Chief Physician
- Director, Cardiology Ward, Wuhan Asia Heart Hospital
- Master’s Graduate Supervisor
- Mentor, National Cardiovascular Disease Interventional Diagnosis and Treatment Training Program — Coronary Intervention
- Committee Member, Chinese Society of Cardiology — Women’s Heart Health Group
- Committee Member, Chinese Society of Cardiology — Coronary Heart Disease & Atherosclerosis Group
- Committee Member, Chinese Research Hospitals Hypertension Professional Committee
- Committee Member, Hubei Cardiovascular Prevention Center Continuing Education Steering Committee
- Committee Member, Hubei Preventive Medicine Association Cardiovascular Prevention & Control Committee
- Standing Committee Member, Wuhan Medical Association Cardiovascular Physicians Branch
- Expert, Hubei Medical Malpractice Appraisal Committee
- Expert Reviewer, Wuhan Municipal Science and Technology Bureau
- Visiting Scholar, Epworth Heart Centre, Australia
Her appointment as Chief Physician and postgraduate supervisor can be independently verified in Wuhan University of Science and Technology’s graduate supervisor records, and her Chief Physician title is also documented in Hubei’s senior professional-title approval records.
Selected Publications & Academic Contributions
- Wang M, et al. [2026 female arrhythmia consensus]. Chinese Journal of Cardiology. 2026;54(4):378–389. Expert Contributor.
- Wang M, et al. Expert Consensus on the Management of Hypertension in Women. Chinese Journal of Cardiology. 2025;53(8):872–881. DOI: 10.3760/cma.j.cn112148-20250317-00199. Expert Group Member.
- Zhang H, Wang L, Shangguan HJ, Wang M, Yan H. Clinical Study of the Impact of Coronary Microvascular Obstruction on Long-Term Cardiac Function and Prognosis in Patients with Acute ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention. Chinese Journal of Interventional Cardiology. 2025;33(6):327–333.
- Bao Y, Chen L, Wang M, Ma J. Successful Treatment of Double-Layer In-Stent Restenosis Using Shockwave Intravascular Lithotripsy Combined with Excimer Laser Coronary Angioplasty: A Case Report. Journal of Cardiovascular & Pulmonary Diseases. 2024;43(6):629–631. DOI: 10.3969/j.issn.1007-5062.2024.06.015.
- Shangguan HJ, Guo H, Chen WW, et al. Efficacy and Safety of Drug-Coated Balloon in Emergency Coronary Intervention for ST-Segment Elevation Myocardial Infarction. Chinese Journal of Cardiovascular Research. 2024;22(12):1113–1117. DOI: 10.3969/j.issn.1672-5301.2024.12.011.
- Bao Y, Wang M, Ma J. Study on the Curative Effect of Vericiguat in Patients with Heart Failure with Reduced Ejection Fraction. Modern Medicine & Health. 2024;40(16):2764–?. DOI: 10.3969/j.issn.1009-5519.2024.16.014.
- A Rare Case of Hypoplasia of the Left Anterior Descending Artery. Journal of Cardiovascular & Pulmonary Diseases. 2024;43(11):1196–1198. DOI: 10.3969/j.issn.1007-5062.2024.11.12.
- Wang M, et al. Expert Consensus on the Diagnosis and Treatment of Coronary Heart Disease in Women in China. Chinese Journal of Cardiology. 2023;51(2):125–135. Core Expert Group Member.
- Luo WS, Wang M, Chen L. Accuracy and Latest Research Progress of Quantitative Flow Ratio Evaluation Based on Fractional Flow Reserve. West China Medical Journal. 2023;38(1):121. DOI: 10.7507/1002-0179.202208032.
- Wang LJ, Wang M, et al. Transcatheter Aortic Valve Replacement Reduces the Incidence of Severe Ventricular Arrhythmia in Patients with Aortic Valve Stenosis. Journal of Internal Medicine in Critical Care. 2021;27(3). DOI: 10.11768/nkjwzzzz20210307.
- Shangguan HJ, Wang M, Guo H, Xiong QF. Case Study and Literature Review of Stress Cardiomyopathy with Cardiogenic Shock. Huaihai Medicine. 2021;39(2):116–119. DOI: 10.14126/j.cnki.1008-7044.2021.02.003.
- Xu CY, Liu XT, Liu CW, et al. Effect of Early Intervention on 12-Month Clinical Outcomes in Patients with High-Risk Non-ST-Segment Elevation Acute Coronary Syndrome. Chinese Journal of Interventional Cardiology. 2018;26(1):24–30.
- Xu CY, Li M, Song D, et al. Use of the CrossBoss™ Catheter for Coronary Chronic Total Occlusions. Chinese Journal of Cardiovascular Medicine. 2018;23(1):51–54. DOI: 10.3969/j.issn.1007-5410.2018.01.012.
- Wang M, et al. Platelet Reactivity in Patients with Acute Coronary Syndrome and Diabetes Mellitus Undergoing Percutaneous Coronary Intervention and Dual Antiplatelet Therapy with Clopidogrel or Ticagrelor. Chinese Heart Journal. 2017;29(3). DOI: 10.13191/j.chj.2017.0073.
- Wang M, Shuang DS, Su X. Comparison of Residual Platelet Reactivity and Prognosis After Clopidogrel Versus Ticagrelor in Patients with Acute Coronary Syndrome and Type 2 Diabetes Mellitus. Chinese Journal of Interventional Cardiology. 2016;24(12):677–682.
- Wei JF, Yan H, Song D, et al. Comparison of Clinical Outcomes Between Domestic Sirolimus-Eluting Stents and Imported Zotarolimus-Eluting Stents for Unprotected Left Main Coronary Artery Disease. Chinese Journal of Interventional Cardiology. 2015;23(11):617–621.
- Shuang DS, Wang M, et al. Comparison of Two Angiography-Based Methods for Predicting Fractional Flow Reserve. Chinese Journal of Interventional Cardiology. 2015;23(6):301–304. DOI: 10.3969/j.issn.1004-8812.2015.06.002.
- Shuang DS, Wang M, et al. Research Progress of Forecasting Myocardial Fractional Flow Reserve (FFR) Based on Coronary Angiography Images. Chinese Continuing Medical Education. 2015;7(16):29.